- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01914224
Combined Dietary Education of Low Sodium and High Potassium Consumption
Research for the Effectiveness of Combined Dietary Education of Low Sodium and High Potassium Consumption
Reduction in sodium consumption is important approach in public health care. In general population, reduction of sodium intake can reduce the future development of hypertension and cardiovascular event. Meanwhile, enhancement of potassium consumption is also important to reduce blood pressure and cardiovascular events. We hypothesized that combined education of low sodium and high potassium consumption is more effective in reducing blood pressure compared to dietary education of low sodium consumption only.
The present survey study was designed to test the effectiveness of combined education of low sodium and high potassium consumption in blood pressure reduction and improvement of other variables.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Gyeonggi
-
Goyang, Gyeonggi, Korea, Republikken, 410-773
- Rekruttering
- Dongguk University Ilsan Hospital
-
Kontakt:
- Moo-Yong Rhee, MD, PhD
- Telefonnummer: 82 31 961 7125
- E-mail: mooyong.rhee@gmail.com
-
Kontakt:
- Ji-Hyun Kim, MD, PhD
- Telefonnummer: 82 31 961 7270
- E-mail: mdangela79@gmail.com
-
Underforsker:
- Ji-Hyun Kim, MD, PhD
-
Ledende efterforsker:
- Moo-Yong Rhee, MD, PhD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Prehypertension: with a systolic pressure from 120 to 139 mm Hg or a diastolic pressure from 80 to 89 mm Hg
- Stage 1 hypertension: with a systolic pressure from 140 to 159 mm Hg or a diastolic pressure from 90 to 99 mm Hg
Exclusion Criteria:
- Urinary tract disease
- Secondary hypertension
- Previous history of unstable angina, heart failure, myocardial infarction, coronary revascularization, cerebrovascular disease within 12 months
- Ventricular tachycardia, atrial fibrillation and flutter
- Hypertrophic cardiomyopathy
- Known chronic kidney disease: serum creatinine = or > 2.0 mg/dL
- Hypokalemia (<3.5 mmol/L) or hyperkalemia (>5.5 mmol/L)
- Type 1 diabetes mellitus
- Poorly controlled diabetes mellitus (HbA1C = or > 9%)
- Unable to collect 24 hour urine sample
- Pregnancy
- Alcoholics
- Severe liver disease
- Night workers
- Mental retardation
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Group 1
dietary education of low sodium and high potassium consumption
|
|
|
Aktiv komparator: Group 2
dietary education of low sodium consumption only
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
changes of 24-hour ambulatory systolic and diastolic blood pressure
Tidsramme: 3 months
|
Effectiveness of combined dietary education of low sodium and high potassium consumption on changes of 24-hour ambulatory systolic and diastolic blood pressure, compared to dietary education of low sodium consumption only.
|
3 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
changes of 24-hour urine sodium and potassium excretion
Tidsramme: 3 months
|
Difference of changes of 24-hour urine sodium and potassium excretion by each dietary education
|
3 months
|
|
changes of renin and aldosterone
Tidsramme: 3 months
|
Difference in changes of renin and aldosterone by each dietary education
|
3 months
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes of renin and aldosterone
Tidsramme: 3 months
|
Changes of renin and aldosterone by low sodium consumption
|
3 months
|
|
Changes of pulse wave velocity
Tidsramme: 3 months
|
Changes of pulse wave velocity by low sodium consumption
|
3 months
|
|
Changes of left ventricular mass index
Tidsramme: 3 months
|
Changes of left ventricular mass index by low sodium consumption
|
3 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Moo-Yong Rhee, MD, PhD, Dongguk University
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 13162MFDS106
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Forhøjet blodtryk
-
VIVUS LLCIkke rekrutterer endnuPulmonal arteriel hypertension | Pulmonal arteriel hypertension (PAH) (WHO Group 1 PH) | Pulmonal arteriel hypertension (PAH) | Pulmonal arteriel hypertension WHO gruppe I | Pulmonal arteriel hypertension PAH
-
Philipps University MarburgMSD Sharp & Dohme GmbH, GermanyIkke rekrutterer endnu
-
BayerAfsluttet
-
National Taiwan University Hospital Hsin-Chu BranchRekrutteringHypertension, essentiel | Hypertension, maskeretTaiwan
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc...Ikke rekrutterer endnuPulmonal hypertension | Pulmonal arteriel hypertension (PAH)Forenede Stater
-
BackBeat Medical IncIkke rekrutterer endnuHypertension, systolisk | Hypertension (HTN) | Hjertesvigt med bevaret ejektionsfraktion (HFpEF)Georgien
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of MichiganIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)Forenede Stater
-
University of Sao Paulo General HospitalRekrutteringPulmonal arteriel hypertension (PAH)Brasilien
-
University Hospital, BrestIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)Frankrig
-
Shanghai Zhongshan HospitalIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)